Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PHARMACEUTICALS

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

POLYSILOXANE D5 CRS (50 MG)

POLYSILOXANE D5 CRS (50 MG)

ND

DISCOVER
POLYSILOXANE D6 CRS (50 MG)

POLYSILOXANE D6 CRS (50 MG)

ND

DISCOVER
FLUTICASONE PROPIONATE FOR SYSTEM SUITABILITY A CRS (0.2 MG)

FLUTICASONE PROPIONATE FOR SYSTEM SUITABILITY A CRS (0.2 MG)

ND

DISCOVER
TESTOSTERONE ENANTATE IMPURITY A CRS (91 MG)

TESTOSTERONE ENANTATE IMPURITY A CRS (91 MG)

ND

DISCOVER
TESTOSTERONE ENANTATE IMPURITY K CRS (0.02 MG)

TESTOSTERONE ENANTATE IMPURITY K CRS (0.02 MG)

ND

DISCOVER
PROCAINE FOR SYSTEM SUITABILITY CRS (1.01 MG)

PROCAINE FOR SYSTEM SUITABILITY CRS (1.01 MG)

ND

DISCOVER
OXALIC ACID DIHYDRATE CRS (20MG)

OXALIC ACID DIHYDRATE CRS (20MG)

ND

DISCOVER
Zolpidem

Zolpidem

82626-48-0

DISCOVER
Zeranol

Zeranol

55331-29-8

DISCOVER
Ziprasidone

Ziprasidone

146939-27-7

DISCOVER
Zoledronic acid monohydrate

Zoledronic acid monohydrate

165800-06-6

DISCOVER
Zofenopril Calcium Salt

Zofenopril Calcium Salt

81938-43-4

DISCOVER